W.P. Carey pays $468M US to acquire Apotex GTA properties
U.S.-based REIT W.P. Carey (WPC-N) will invest $468 million US to acquire a “critical portfolio of four pharmaceutical R&D and manufacturing campuses” in the Greater Toronto Area from generic drug giant Apotex Pharmaceutical Holdings Inc.
